Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Evaluation of Facial and Neck Skin Laxity With SofWave Treatment in Adults Initiating Tirzepatide for Weight Loss

NCT: NCT07685834 · ACTIVE_NOT_RECRUITING

NCT IDNCT07685834
StatusACTIVE_NOT_RECRUITING
Start Date2026-02-27
Completion2027-03-01
SponsorSofwave Medical LTD (INDUSTRY)
First posted
Last updated

Brief Summary

Open-label, randomized double-arm prospective, single-center, self-controlled clinical study.

Frequently Asked Questions

What is Evaluation of Facial and Neck Skin Laxity With SofWave Treatment in Adults Initiating Tirzepatide for Weight Loss?

Evaluation of Facial and Neck Skin Laxity With SofWave Treatment in Adults Initiating Tirzepatide for Weight Loss is a clinical trial registered under NCT07685834. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT07685834?

The current status of NCT07685834 (Evaluation of Facial and Neck Skin Laxity With SofWave Treatment in Adults Initiating Tirzepatide for Weight Loss) is: ACTIVE_NOT_RECRUITING.

When did Evaluation of Facial and Neck Skin Laxity With SofWave Treatment in Adults Initiating Tirzepatide for Weight Loss start?

Evaluation of Facial and Neck Skin Laxity With SofWave Treatment in Adults Initiating Tirzepatide for Weight Loss started on 2026-02-27.

Related Devices

K191421Sofacia SystemSofwave Medical, Ltd. K211483SofWave SystemSofwave Medical, Ltd. K223237SofWave SystemSofwave Medical, Ltd. K230019SofWave SystemSofwave Medical, Ltd. K230820SofWave SystemSofwave Medical, Ltd.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑